Determining Cross-Contamination Risks in Multiproduct Biopharmaceutical Facilities

Published on: May 15, 2014

Pharmaceutical Technology, Pharmaceutical Technology-05-15-2014, Volume 2014 eBook, Issue 2

A global contract manufacturer of biologics discusses the increasing impact of health-based exposure limits in assessing cross-contamination risks.

A global contract manufacturer of biologics discusses the increasing impact of health-based exposure limits in assessing cross-contamination risks.

Download